FDA approves first at-home, over-the-counter test for STIs. But there's a catch.
Show Caption
Hide Caption
Where to get tested for STIs
Sexually transmitted infections are on the rise. Here's where to get properly tested.
Self Improved, Self Improved
The U.S. Food and Drug Administration (FDA) has approved the first-ever testing kit for sexually transmitted infections that can be taken at home without a prescription. But it's not for everyone.
The FDA granted marketing authorization for the diagnostic test, the Visby Medical Women's Sexual Health Test, to Visby Medical on Friday. The at-home kit, according to the FDA, is the first of its kind to test for chlamydia, gonorrhea and trichomoniasis, three of the most common STIs with symptoms that often go unnoticed.
The kit is intended for use in female patients with or without symptoms. It is single-use and includes a vaginal swab and a powered testing device that connects to the Visby Medical App. Results are displayed on the app about 30 minutes after testing.
An FDA press release issued Friday said the test was 97% to 100% accurate when identifying the presence or absence of the three STIs in women with or without symptoms. The release advised that those who test positive should seek medical care and those who have symptoms, recent exposure or other concerns should still contact their healthcare provider even if they get a negative result.
'Home tests can give people information about their health from the privacy of their home. This can be particularly important for sexual health tests for which patients may experience fear or anxiety, possibly resulting in delayed diagnosis or treatment,' Courtney Lias, director of the Office of In Vitro Diagnostic Devices in the FDA's Center for Devices and Radiological Health, said in a statement.
'Expanding access to tests for sexually transmitted infections is an important step toward earlier and increased diagnosis, which can result in increased treatment and reduced spread of infection.'
The approval of this test opens the pathway for more at-home STI testing in the future, said the statement.
At-home test tackles three most common STIs
Chlamydia, gonorrhea and trichomoniasis are three of the most prevalent STIs in the U.S.
Both chlamydia and gonorrhea are bacterial infections, while trichomoniasis is caused by a parasite. Gonorrhea can cause infection in the genitals, rectum and throat and often has no symptoms, according to the Centers for Disease Control and Prevention (CDC). Chlamydia is also typically asymptomatic but can cause permanent damage to a woman's reproductive system.
Trichomoniasis is caused by a one-celled protozoan, a type of tiny parasite called Trichomonas vaginalis. In 2021, the CDC reported that around 2.6 million Americans had been infected with trichomoniasis. Up to 70% of people have no symptoms when infected.
According to the CDC's (STI) Surveillance Report, 601,319 cases of gonorrhea were reported in the U.S. in 2023, making it the second most common STI in the country. There were more than 1.6 million reported cases of chlamydia in the same year, making it the most common.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
an hour ago
- Business Upturn
Why XentaFlex Is Emerging as 2025's Most Affordable, Simplest, and Most Effective Joint Pain Solution
Salt Lake City, Aug. 04, 2025 (GLOBE NEWSWIRE) — A growing number of Americans are questioning the same outdated joint pain 'remedies' they've relied on for years in 2025. From glucosamine pills to endless collagen powders, solutions once trusted by doctors and influencers alike are now being blamed for worsening pain — not solving it. A powerful shift is underway as consumers turn toward science-backed alternatives rooted in natural compounds and cellular hydration. At the center of this movement? A new ingredient-first formula called XentaFlex that's rapidly gaining attention for its unique 'water hack' delivery system and ability to flush what experts are now calling the root cause of joint discomfort. If your joints feel stiff, swollen, or unreliable no matter what you try — and you've been told 'it's just age' — it may be time to question everything. 2025 is ushering in a seismic shift in joint care, and many believe this might be the breakthrough they've been waiting for. From Reddit to TikTok to the fields of clinical nutrition, curiosity around the real root cause of joint collapse is exploding — and it's leading consumers to one product: XentaFlex. Explore the Full Simple Promise XentaFlex Formula and discover why thousands are making the switch to a more modern approach to joint health. DISCLAIMER: This article is for informational purposes only and is not intended as medical advice, diagnosis, or treatment. The content reflects public discussions, scientific exploration, and consumer trends only. Always consult a qualified healthcare provider before starting any supplement, lifestyle change, or health-related product. This content may include promotional links. The publisher or author may receive compensation through affiliate partnerships, which does not influence editorial integrity or the price you pay. Results may vary. Use of this information is at your own discretion. WHY INTEREST IN 'JOINT PAIN SOLUTIONS' IS SURGING IN 2025 Joint pain has quietly become one of the most searched health concerns of 2025 — not just among seniors, but across all age groups. From 30-something desk workers dealing with early stiffness to retirees fighting to avoid another round of surgery, millions are asking the same question: 'Why do my joints hurt, and why isn't anything working?' This surge in interest isn't random. According to Google Trends, terms like 'joint pain cure,' 'natural joint support,' 'water for joint pain,' and 'what is S-1 toxin?' have all exploded in search volume over the past year. On platforms like TikTok, influencers are ditching traditional capsules in favor of so-called 'sweet water hacks' — colorful, citrusy drinks that claim to reduce stiffness and restore mobility. Meanwhile, Reddit forums like r/supplements and r/medicalmedium are flooded with joint detox stories, cautionary tales about collagen overload, and thousands of users comparing notes on new alternatives to aging mainstream treatments. The common thread across all platforms? Skepticism toward the old guard — pills like glucosamine and chondroitin, injections, and prescription painkillers that often mask symptoms without addressing deeper root causes. What used to be accepted without question is now under scrutiny. Consumers are doing their own research, diving into ingredient labels, peer-reviewed journals, and asking: 'What's really going on inside my joints?' This mass rethinking is also fueled by frustration. Many Americans feel they've done everything right — taken supplements, worn braces, followed rehab plans — and still face pain that won't let up. It's no surprise that conversations are shifting toward causes previously ignored by traditional medicine. A growing number of voices are pointing to deeper cellular issues, especially the buildup of a lesser-known joint toxin called S-1, as the possible 'invisible culprit' behind Cushion Collapse and joint degeneration. Whether sparked by frustration, curiosity, or TikTok virality, the public's interest in joint health has evolved from passive acceptance to active investigation. And it's this environment of information-hungry consumers that's giving rise to innovative new solutions — especially those like XentaFlex that speak directly to what the public is searching for. SIMPLE PROMISE XENTAFLEX'S INGREDIENT-FIRST RESPONSE TO THESE TRENDS In a world flooded with painkillers, capsules, collagen powders, and glucosamine drinks, XentaFlex stands apart for one powerful reason: it doesn't follow the rules that created the problem in the first place. Instead, it responds to what real people are asking in 2025 — 'What's inside this formula, and how does it align with the latest discoveries around joint pain?' Rather than market itself as another miracle pill, XentaFlex is built around a water-soluble, daily drinkable formula designed specifically to address modern concerns: ingredient overload, capsule fatigue, poor absorption, and overhyped claims. The team behind XentaFlex understood that today's consumers are skeptical. They've been burned by bold promises. So instead of hype, the formula delivers transparency — starting with a short list of clinically-backed, naturally derived compounds known for their unique relationship to joint health. Unlike traditional pills that require up to a dozen ingredients just to be effective — many of which compete in the body — XentaFlex is built around a synergistic core of just five targeted nutrients, each chosen not for trendiness, but for compatibility, absorption, and scientific relevance in 2025. The lead compound? A patented form of Boswellia called AquaLox™. Its inclusion is no accident. According to public research, it's one of the most heavily studied joint-related plant extracts in recent years — not for what it claims to do, but for how it's been clinically explored in connection with a toxin now known as S-1, which has captured major attention as a potential contributor to Cushion Collapse and joint tissue degradation. But XentaFlex doesn't stop there. While AquaLox™ forms the 'flush' layer of the formula, it's supported by Regen™, a rare and purified blend of fulvic and humic acid — micronutrients that are getting major buzz in longevity and cellular hydration circles. These minerals are naturally occurring in nutrient-dense soils, but due to modern farming practices, they've been virtually stripped from the food supply. Their inclusion in XentaFlex reflects a growing movement in functional health: the return to soil-based, bioavailable nutrition. Then there's Taurine, long explored in performance science for its antioxidant behavior and muscle support. In the context of XentaFlex, it's positioned within new discussions about recovery and cellular protection from environmental stressors that may contribute to joint discomfort. The formula is rounded out by potassium chloride and sea salt trace minerals, included not for flavor, but to restore the mineral balance many nutrition experts now believe is essential for optimal joint hydration. In fact, the idea that 'cartilage acts like a sponge' has become a central metaphor in the new science of movement — and XentaFlex is one of the few consumer formulas designed around that concept. Also worth noting is what's not in the formula. No collagen. No glucosamine. No chondroitin. No binders. No sugars. No hidden preservatives. That's not a marketing trick — it's a response to public conversations happening in real-time. Scroll through wellness subreddits, Amazon reviews, and YouTube comment threads, and you'll see people begging for simpler, cleaner options that make sense in today's world. XentaFlex doesn't ask users to 'trust' the label. It invites them to understand it — and that subtle but powerful difference is why many are turning to this formula as a first step in exploring a completely different approach to joint relief. INGREDIENT SPOTLIGHT — WHAT'S INSIDE THE FORMULA What makes XentaFlex different isn't just the ingredients it includes — it's the way they're combined, absorbed, and positioned around a newly explored root cause of joint pain that's rapidly gaining attention in 2025: S-1 accumulation. With more users turning to 'water-based' solutions for daily wellness, XentaFlex focuses on compounds that dissolve fast, absorb easily, and align with emerging research trends — not outdated supplement theory. At the core of the formula is AquaLox™, a patented and purified form of Boswellia serrata. This ingredient is frequently discussed in wellness forums and explored in multiple human studies for its interaction with a newly identified joint toxin known as Stromelysin-1 (S-1). What's significant about AquaLox™ isn't just the origin plant — it's the technology behind it. While most forms of Boswellia offer limited bioavailability and require large doses to have any effect, AquaLox™ is water-soluble and absorbs up to 111% more efficiently than older extract types. This aligns with recent consumer behavior trends favoring fast-acting, low-effort formats — like daily morning drinks instead of handfuls of capsules. Just behind AquaLox™ is Regen™, a trademarked compound sourced from fulvic and humic acid minerals found deep in the Himalayan soil. Regen™ is currently being explored for its trace mineral density and potential role in cellular hydration, circulation, and nutrient absorption — all of which are topics dominating current wellness conversations on platforms like TikTok and YouTube. According to researchers, fulvic compounds may support the body's ability to flush stored toxins, a concept many associate with the growing 'internal cleanse' and 'detoxification' trends happening in 2025. Together, AquaLox™ and Regen™ form what many in the functional health space describe as a 'flush and fortify' strategy: one compound helps support natural elimination of joint toxins, while the other may help replenish the minerals and nutrients stripped from the modern food supply. But the formula doesn't stop there. XentaFlex also includes Taurine, an amino acid widely recognized for its role in recovery, cellular function, and antioxidant support. Although commonly discussed in fitness circles, Taurine is now emerging as a key component in mobility-focused protocols thanks to recent research connecting it to inflammation-related signaling — especially in older adults who remain active. In the context of joint health, Taurine's inclusion reflects a broader move toward multi-layered protection — not just temporary comfort. Supporting these core ingredients is a carefully selected blend of potassium chloride and sea salt-derived trace minerals. These are not added for flavor. They're there because hydration science now shows how important mineral balance is for maintaining healthy joint function — especially when cartilage is described less like a cushion and more like a hydration sponge. In modern wellness culture, this concept has gained traction as users explore 'mineral stacking,' 'electrolyte optimization,' and even 'internal joint soaks' through hydration-centric routines. Many of the trends and scientific references behind these ingredients are publicly available, and consumers are taking notice. According to a recent report on user-generated search behavior, keywords like 'Boswellia water benefits,' 'mineral support for joints,' and 'S-1 toxin symptoms' have all surged — signaling a move away from traditional advice and toward formulas that reflect current findings. What's equally important is that XentaFlex is free from hidden binders, fillers, sugars, artificial sweeteners, and bulking agents. It doesn't include glucosamine or chondroitin — compounds that have dominated the joint space for decades but are now being actively questioned by Redditors, YouTubers, and even academic commentators. This clean-label, ingredient-first design is precisely why more people are switching to XentaFlex not just for how it works, but for what it stands for. It's a formulation born out of frustration, modern science, and real-world use cases — and for those seeking a deeper, smarter approach to joint support in 2025, it may be the perfect fit. To experience the full breakdown and ingredients firsthand, explore the Full Simple Promise XentaFlex Formula and see why so many are switching to the new standard in joint care. WHAT REDDIT, PODCASTS & TIKTOK CREATORS ARE SAYING Social platforms like Reddit, YouTube, and TikTok have become the new front lines in the conversation around joint health in 2025. What used to be dominated by academic journals and supplement industry claims is now unfolding in comment threads, creator videos, and podcast monologues — all driven by everyday users sharing their frustrations, questions, and unexpected wins. Reddit, in particular, has seen a wave of threads across communities like r/supplements, r/biohackers, and r/medicalmedium where people are no longer asking for the 'best joint pill,' but instead comparing alternative approaches. Topics like 'how hydration affects cartilage,' 'toxins that stiffen joints,' and 'Boswellia vs. collagen' are trending, with thousands of upvotes fueling hours of peer-to-peer debate. The shift is clear: people want joint solutions that make sense for their lifestyles, not just another generic vitamin blend pushed by big brands. Meanwhile, TikTok's short-form video format has birthed an entirely new genre of joint health content. Creators are posting everything from '7-day pain reset' routines to DIY 'joint hydration recipes,' usually centered around vibrant-colored drink mixes and routines like morning citrus-mint elixirs. These clips rack up millions of views not because they promise cures, but because they reflect a shared curiosity: Is there a simpler, tastier way to support joint health daily? Podcasts have also caught on. While many still interview physical therapists or sports doctors, the most popular episodes are often those that explore the why behind discomfort — asking questions like 'What's really causing joint stiffness?' or 'Are modern supplements missing something critical?' In this space, creators frequently explore emerging topics like the S-1 toxin, Cushion Collapse, and the idea that minerals, not just anti-inflammatories, may be the missing piece in the joint support equation. What makes this trend so powerful isn't just the volume of content — it's the tone shift . Creators aren't just parroting marketing lines or repeating clinical studies. They're documenting their own journeys, unpacking what worked, what didn't, and what they wish they knew earlier. Many of them have ditched long supplement regimens altogether in favor of what they call 'stacked hydration' protocols — where mineral-rich, plant-powered drinks are used in place of capsules to support movement and recovery throughout the day. Formulas like XentaFlex are increasingly referenced not as miracle cures, but as examples of ingredient stacks that reflect the current direction of public research. No capsules, no complicated rituals — just real ingredients, made water-soluble, and paired with the same minerals and support compounds that wellness communities are now exploring on their own. If you're seeing this shift and wondering what it's all about, take a closer look at what's inside. Explore the Full Simple Promise XentaFlex Formula and see why social communities are driving awareness of this approach in 2025. WHO MIGHT BE DRAWN TO THIS TYPE OF SUPPLEMENTATION IN 2025 Not long ago, joint supplements were primarily associated with older adults, injury recovery, or post-surgery maintenance. But in 2025, that stereotype has been shattered. Today, an entirely new generation of consumers is seeking out joint support formulas — not just because they're in pain, but because they're proactively looking to stay mobile, energized, and independent for decades to come. So who is turning to solutions like XentaFlex? Let's start with the obvious: those frustrated by traditional capsules and creams that never seem to deliver what they promise. Many users now describe themselves as 'pain-aware' — not because they're defined by discomfort, but because they've lived with it long enough to know what doesn't work. These individuals aren't looking for miracles. They're looking for formulas that align with what they've learned through trial, error, and hours of late-night research. Then there's a growing segment of mobility optimizers — younger adults in their 30s, 40s, and early 50s who aren't in crisis mode, but who feel the subtle signs of wear: a stiff knee in the morning, a sore hip after long walks, or hands that ache after a day at the keyboard. They're not waiting for things to get worse. They're seeking gentle, daily protocols they can stick with long-term — especially ones that taste good, absorb fast, and require no pills. Also entering the conversation are those navigating recovery — not just from injury, but from frustration. People who feel ignored by standard recommendations. Individuals who've been told 'it's just aging,' and sent home with a bottle of painkillers and no answers. For many of them, products like XentaFlex aren't just about relief. They represent a shift in philosophy: that joint care can be proactive, intelligent, and actually enjoyable. A surprising trend is the influx of performance-conscious professionals — desk workers, startup founders, personal trainers — who want their joints to feel as sharp as their minds. For them, supplementation is about clarity, movement, and resilience, not age. They're drawn to formulas that respect their time, lifestyle, and values — which is exactly why fast-dissolving, easy-to-drink powders like XentaFlex are gaining traction in wellness-minded circles. Then there are the independence protectors — aging parents, grandparents, or solo business owners who know the cost of immobility. For them, it's not about looking younger. It's about being able to cook, lift grandkids, tend the garden, or climb stairs without dread. They want products that make it easier to stay active — without the side effects, hassle, or cost of complicated regimens. What connects all these people is mindset — not medical history. They're not waiting for someone to fix them. They're taking joint care into their own hands, and they're drawn to solutions that reflect their values: transparency, simplicity, modern science, and delicious ease-of-use. XentaFlex doesn't promise the world. It simply offers what many are asking for — a better, easier, more informed way to support the body's ability to move, bend, lift, and stretch with confidence. To learn how XentaFlex is meeting the expectations of today's most proactive consumers, Explore the Full Simple Promise XentaFlex Formula and decide if it matches what you're looking for too. EMERGING WELLNESS & PERFORMANCE INNOVATION — 2025 MARKET REFLECTIONS It's no secret that the wellness and supplement landscape is undergoing a radical transformation. In 2025, the rise of performance-focused, non-clinical supplementation isn't just a trend — it's a direct response to how consumers now view their own bodies, their goals, and the future of aging. For decades, the standard approach to joint discomfort relied heavily on pharmaceutical intervention, pain suppression, or endless repetition of outdated supplement stacks. But today's consumer is looking for something else entirely: lifestyle-aligned, results-aware strategies that can be integrated easily into a daily routine without medical oversight or complicated prep. At the heart of this shift is one big realization: health doesn't begin at crisis. It begins at awareness. Whether it's optimizing hydration, exploring anti-fatigue nutrients, or understanding the impact of environmental stressors like air quality and processed food exposure — people are no longer waiting for symptoms to get severe. They're actively seeking out tools that match their desire to stay active, focused, and mobile for as long as possible. The joint health space, in particular, has become a hotbed for innovation — not because people are in more pain, but because they're demanding more elegant solutions. Formulas that skip the horse pills, ditch the dozen-ingredient blends, and replace them with targeted, bioavailable compounds that support movement, hydration, and resilience. Enter XentaFlex — not just as a product, but as a reflection of this next wave in consumer expectations. Its powdered delivery, citrus-mint flavor, and ingredient transparency are all deliberate design choices based on public demand. People want relief, yes — but they also want ease, taste, and trust. And they want it in a format that makes them feel like they're participating in a movement, not just swallowing another product. We're also seeing a surge of interest in multi-dimensional benefits. Users no longer just want 'joint pain support' — they want something that touches on mobility, strength, digestion, mineral balance, and long-term stability. That's why formulas that feature ingredients like AquaLox™, Regen™, Taurine, potassium chloride, and mineral salts are gaining attention. Not because they make wild promises — but because they align with the way performance biohackers, functional medicine experts, and recovery-focused individuals are now thinking about holistic joint function. Even the language has shifted. Terms like 'joint hydration,' 'Cushion Collapse,' and 'S-1 detox' are now part of the public vocabulary. And with that vocabulary comes deeper curiosity — not just about how to feel better, but how to move better, recover faster, and avoid relying on pills or procedures that don't address root-level concerns. This is the future of performance wellness: self-guided, ingredient-transparent, and designed for movement. XentaFlex didn't just anticipate this shift — it was built in direct response to it. If you're tired of generic solutions and ready to explore a smarter, more modern approach to joint performance, Explore the Full Simple Promise XentaFlex Formula and see why more consumers are making the switch. THE PUBLIC DEBATE AROUND BOSWELLIA, JOINT 'WATER HACKS,' AND S-1 With millions of users now searching for alternatives to traditional joint relief, a growing wave of curiosity — and controversy — has emerged around Boswellia-based hydration formulas, so-called 'joint water hacks,' and the newly discussed S-1 joint toxin. These topics, once confined to fringe wellness blogs or alternative medicine circles, are now front and center across Reddit, podcast networks, and even mainstream wellness media. On one side of the conversation, a rising number of wellness advocates and consumers are embracing Boswellia-derived solutions for their simplicity, taste, and alignment with research exploring inflammation-related pathways and natural detoxification. They point to the shift away from capsules and toward daily water-based rituals as a step forward — one that reflects a broader move toward proactive, ingredient-specific wellness. They're not alone. Many of the most-viewed TikTok creators in the joint pain niche are now demonstrating how they mix bright, citrusy powders into morning water routines and cite 'natural flush support' or 'S-1 buildup awareness' as the motivating force behind their switch. Even casual observers are picking up on this language and seeking formulas that feel refreshing, rather than clinical. But not everyone is sold. Skeptics in the functional health space have raised valid concerns. Some question whether Boswellia — even in patented forms like AquaLox™ — can really do what some users believe. Others caution that labeling any compound a 'toxin flusher' walks a fine line and should always be paired with a clear disclaimer and a healthy dose of personal research. And when it comes to S-1, many are asking for more peer-reviewed consensus before embracing it as a universal explanation for joint discomfort. Still, interest continues to grow. As is often the case with emerging wellness concepts, public adoption often outpaces scientific validation, leading to a split between early adopters and those waiting for more data. One thing most observers can agree on: the conversation has changed. People aren't satisfied with vague promises of 'joint support.' They want to know exactly what the ingredient does, how it works in the body, and whether it matches their goals, lifestyle, and risk tolerance. That's why formulas like XentaFlex — which use branded, traceable versions of each core ingredient — are gaining traction. Not because they're louder, but because they're clearer. The debate over joint hydration hacks, Boswellia delivery, and S-1's relevance isn't going away anytime soon. And for many, that's a good thing. Open, educated discussion is what drives smarter products, more responsible marketing, and a healthier public. If you're researching both sides of this debate and want to make your own decision, Explore the Full Simple Promise XentaFlex Formula and learn how its ingredient stack fits into the 2025 conversation around smarter joint support. ABOUT SIMPLE PROMISE™ Simple Promise™ was founded on one principle: transparency leads to trust. In an industry crowded with overpromised benefits and underdisclosed ingredient sources, the Simple Promise team has focused on creating formulas that empower consumers with clarity — not confusion. The company believes that true wellness starts with education, not fear. That's why every Simple Promise formula is built from the ground up with the curious, health-aware consumer in mind — those who read labels, ask questions, and want to understand why each ingredient is there. Rather than follow trends, Simple Promise stays ahead by tapping into the latest research, sourcing branded and traceable compounds, and ensuring that every product reflects the real conversations happening in public wellness spaces. From soil-sourced minerals to modern absorption technology, the brand focuses on designing ingredient-first, lifestyle-friendly formulas that integrate easily into real daily routines. XentaFlex is a natural extension of this philosophy — a joint support powder created not to chase claims, but to align with the shift in how people think about joint mobility, hydration, and toxin awareness. To learn more about how XentaFlex reflects this mission of modern wellness done right, Explore the Full Simple Promise XentaFlex Formula and discover the difference an ingredient-first approach can make. CONTACT Simple Promise XentaFlex Email: [email protected] [email protected] Phone: 1-800-259-9522 1-800-259-9522 Website: FINAL DISCLAIMER This press release is for informational purposes only. The information contained herein does not constitute medical advice, diagnosis, or treatment and has not been evaluated by the Food and Drug Administration (FDA). Simple Promise XentaFlex is not intended to diagnose, treat, cure, or prevent any disease. Always consult your physician or qualified healthcare provider before beginning any new supplement, routine, or health program. Some links in this release may be promotional in nature and may lead to third-party websites. The publisher or author may receive compensation through affiliate commissions if a purchase is made through these links. This compensation does not affect the price you pay and helps support continued research and content publication. Results described or implied may not be typical and should not be interpreted as guarantees. Statements made about ingredients or outcomes reflect public discussion and historical usage only, and are not endorsed by medical professionals or regulatory agencies. Always do your own research and make informed decisions. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
Yahoo
2 hours ago
- Yahoo
DHS: Wisconsin health officials urge vaccinations ahead of new school year, rates below measles safety threshold
(WFRV) – As families across Wisconsin prepare for the new school year, the Department of Heath Services (DHS) has released its latest school vaccination data for 2024-2025. According to a press release from DHS, 86.4% of students met the state's minimum immunization requirements. That's a slight drop from last year, mainly due to a new vaccination rule that requires students in grades 7 though 12 to get the meningococcal vaccine. Our school vaccination data tells us there are children in our schools who are not protected from an outbreak of preventable diseases like measles. Health Officer Paula Tran. Smoky conditions remain in Wisconsin early this week When this new requirement is excluded, the overall vaccination rate increased slightly, reaching 89.3%, up to 0.1% last year. Meanwhile, national data from the CDC shows Wisconsin kindergartners still lag behind many other states in protecting kids against vaccine-preventable illnesses. Health officials urge parents to make sure their children are up to date on all required vaccine before school starts. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. Solve the daily Crossword
Yahoo
2 hours ago
- Yahoo
Innovent Receives U.S. FDA Approval for IND Application of Oral GLP-1R Agonist IBI3032
SAN FRANCISCO and SUZHOU, China, Aug. 4, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announced that the U.S. Food and Drug Administration (FDA) has approved the investigational new drug (IND) application to initiate a Phase 1 clinical trial of IBI3032, the company's novel oral GLP-1R agonist. IBI3032 is an orally administered small-molecule GLP-1 receptor agonist with bias for cAMP signaling pathway, discovered and developed by Innovent Biologics with proprietary rights. Preclinical data demonstrate its superior pharmacokinetic (PK) and physicochemical properties compared to peer compounds. In animal models, IBI3032 achieved 5 to 10 times higher oral exposure at equivalent doses, with improved efficacy and good tolerability in both GLP-1R KI DIO mice and obese monkey models, achieving comparable therapeutic effects at lower doses. The Phase 1 clinical trials of IBI3032 are planned to be conducted concurrently in China and the U.S. Dosing in healthy volunteers and overweight or obese participants is expected to begin in the second half of 2025. Innovent is building up its CVM pipeline with mazdutide as the cornerstone, and the initiation of the IBI3032 clinical study marks a significant step in the evolution of its CVM pipeline portfolio with global potential. Dr. Lei Qian, Chief R&D Officer for General Biomedicines Pipeline at Innovent Biologics, said, "GLP-1 has emerged as a blockbuster target over the past decade. Its oral form, with its convenience, flexibility, and unique advantage in combination treatment strategies, holds promise as a differentiated complement to GLP-1R-targeting biologicals. Beyond traditional applications in diabetes and weight management, oral GLP-1 possess potential in treating related diseases such as hypertension and OSA (obstructive sleep apnea). IBI3032 has demonstrated its promising efficacy profiles in animal models, where IBI3032 exhibited a longer elimination half-life and higher drug exposure levels than its competitors at the same dose. We are excited to advance this candidate into clinical development. This IND approval reflects Innovent's strong R&D capabilities and, most importantly, our commitment to global innovation. We hope that in the near future, IBI3032 can offer more effective and convenient treatment options to benefit patients around the world. " About IBI3032 IBI3032 is a novel oral small molecule glucagon-like peptide-1 receptor agonist (GLP-1RA). By efficiently and selectively targeting GLP-1R, it activates downstream signal transduction, thereby delaying gastric emptying, inhibiting appetite, and promoting insulin secretion, and ultimately supporting the treatment of insulin-related metabolic diseases such as obesity and T2DB. Discovered through a structure-based drug design (SBDD) strategy combined with systematic physicochemical property optimization, IBI3032 has shown better PK and physicochemical properties compared to similar compounds. The IND application of IBI3032 was accepted by China's National Medical Products Administration (NMPA) and approved by the U.S. Food and Drug Administration (FDA). A multi-regional Phase 1 clinical study of IBI3032 is planned for initiation in the second half of 2025. About Innovent Biologics Innovent is a leading biopharmaceutical company founded in 2011 with the mission to empower patients worldwide with affordable, high-quality biopharmaceuticals. The company discovers, develops, manufactures and commercializes innovative medicines that target some of the most intractable diseases. Its pioneering therapies treat cancer, cardiovascular and metabolic, autoimmune and eye diseases. Innovent has launched 16 products in the market. It has 2 new drug applications under regulatory review, 4 assets in Phase III or pivotal clinical trials and 15 more molecules in early clinical stage. Innovent partners with over 30 global healthcare companies, including Eli Lilly, Sanofi, Incyte, LG Chem and MD Anderson Cancer Center. Guided by the motto, "Start with Integrity, Succeed through Action," Innovent maintains the highest standard of industry practices and works collaboratively to advance the biopharmaceutical industry so that first-rate pharmaceutical drugs can become widely accessible. For more information, visit or follow Innovent on Facebook and LinkedIn. Statement: （1）Innovent does not recommend the use of any unapproved drug (s)/indication (s). （2）Ramucirumab (Cyramza)，Selpercatinib (Retsevmo) and Jaypirca (pirtobrutinib) were developed by Eli Lilly and Company. Forward-Looking Statements This news release may contain certain forward-looking statements that are, by their nature, subject to significant risks and uncertainties. The words "anticipate", "believe", "estimate", "expect", "intend" and similar expressions, as they relate to Innovent Biologics, Inc. ("Innovent" or "Company"), are intended to identify certain of such forward-looking statements. The Company does not intend to update these forward-looking statements regularly. These forward-looking statements are based on the existing beliefs, assumptions, expectations, estimates, projections and understandings of the management of the Company with respect to future events at the time these statements are made. These statements are not a guarantee of future developments and are subject to risks, uncertainties and other factors, some of which are beyond the Company's control and are difficult to predict. Consequently, actual results may differ materially from information contained in the forward-looking statements as a result of future changes or developments in our business, the Company's competitive environment and political, economic, legal and social conditions. The Company, the Directors and the employees of the Company assume (a) no obligation to correct or update the forward-looking statements contained in this site; and (b) no liability in the event that any of the forward-looking statements does not materialize or turn out to be incorrect. View original content: SOURCE Innovent Biologics Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
